KR19990082054A - 대장암의 억제 방법 - Google Patents

대장암의 억제 방법 Download PDF

Info

Publication number
KR19990082054A
KR19990082054A KR1019980705775A KR19980705775A KR19990082054A KR 19990082054 A KR19990082054 A KR 19990082054A KR 1019980705775 A KR1019980705775 A KR 1019980705775A KR 19980705775 A KR19980705775 A KR 19980705775A KR 19990082054 A KR19990082054 A KR 19990082054A
Authority
KR
South Korea
Prior art keywords
compound
formula
cancer
cells
compounds
Prior art date
Application number
KR1019980705775A
Other languages
English (en)
Korean (ko)
Inventor
마리아 엘. 브랜디
프란체스코 토넬리
Original Assignee
피터 지. 스트링거
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by 피터 지. 스트링거, 일라이 릴리 앤드 캄파니 filed Critical 피터 지. 스트링거
Publication of KR19990082054A publication Critical patent/KR19990082054A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
KR1019980705775A 1996-01-29 1997-01-27 대장암의 억제 방법 KR19990082054A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
US60/010,772 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
GB9603150.5 1996-02-15

Publications (1)

Publication Number Publication Date
KR19990082054A true KR19990082054A (ko) 1999-11-15

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980705775A KR19990082054A (ko) 1996-01-29 1997-01-27 대장암의 억제 방법

Country Status (19)

Country Link
EP (1) EP0921799A4 (cs)
JP (1) JP2000503994A (cs)
KR (1) KR19990082054A (cs)
CN (1) CN1209745A (cs)
AR (1) AR010978A1 (cs)
AU (1) AU707892B2 (cs)
BR (1) BR9700778A (cs)
CO (1) CO4761062A1 (cs)
CZ (1) CZ235498A3 (cs)
EA (1) EA001104B1 (cs)
ID (1) ID15917A (cs)
IL (1) IL125521A (cs)
MX (1) MX9806036A (cs)
NO (1) NO983451D0 (cs)
NZ (1) NZ331105A (cs)
PL (1) PL328147A1 (cs)
TW (1) TW446560B (cs)
WO (1) WO1997026877A1 (cs)
YU (1) YU2397A (cs)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
JPH07149638A (ja) * 1993-10-15 1995-06-13 Eli Lilly & Co 耐性新生物の治療法
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
AU707892B2 (en) 1999-07-22
EA001104B1 (ru) 2000-10-30
ID15917A (id) 1997-08-21
NO983451L (no) 1998-07-27
YU2397A (en) 1999-11-22
MX9806036A (es) 1998-11-29
BR9700778A (pt) 1998-10-06
EP0921799A1 (en) 1999-06-16
TW446560B (en) 2001-07-21
PL328147A1 (en) 1999-01-18
AR010978A1 (es) 2000-08-02
CN1209745A (zh) 1999-03-03
IL125521A0 (en) 1999-03-12
JP2000503994A (ja) 2000-04-04
WO1997026877A1 (en) 1997-07-31
EA199800677A1 (ru) 1999-02-25
AU2123997A (en) 1997-08-20
NZ331105A (en) 2000-06-23
CZ235498A3 (cs) 1999-02-17
NO983451D0 (no) 1998-07-27
IL125521A (en) 2001-11-25
EP0921799A4 (en) 2002-03-13
CO4761062A1 (es) 1999-04-27

Similar Documents

Publication Publication Date Title
EP0652004B1 (en) Methods for treating resistant neoplasms
EP0680758A1 (en) Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
PT652000E (pt) Metodos para a inibicao de angiogenese e doencas angiogenicas
US5843974A (en) Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
MXPA97009466A (en) Medicine to inhibit the melan
KR19990064099A (ko) 플라스미노겐 활성인자 억제물질 1의 억제 방법
KR19990082054A (ko) 대장암의 억제 방법
US5843964A (en) Methods of inhibiting endometrial mitoses
AU688112B2 (en) Methods of inhibiting endometrial cancer
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
KR19990082055A (ko) 근육건막성 섬유종증(유건종)의 억제 방법
EP0729755A2 (en) 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
CA2244112A1 (en) Methods of inhibiting colon tumors
JPH08253417A (ja) 脳又はｃｎｓのエストロゲン陽性腫瘍抑制用製剤
JPH03502806A (ja) ガンの処理
MXPA97006520A (en) Methods to inhibit the ova cancer

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application